Lyrica produces 'significant' improvement in restless legs syndrome
The drug maker said Lyrica produced statistically significant improvements in patients with RLS compared with placebo and pramipexole after 12 weeks of treatment.
Toronto, May 11 Restless legs syndrome tends to run in families, and the siblings of those who are severely affected seem to have a greater risk of developing the disease, says a new report.